NT5E and pulmonary fibrosis: Here, we focus on interactions between radiotherapy and CD73/adenosine-targeting strategies in subacute pneumonitis that need to be distinguished from potential overlapping chronic adverse effects (e.g., pulmonary fibrosis), which we have already reviewed elsewhere (De Leve et al., 2019a; De Leve et al., 2019b).